SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Faruk Uguz, A pharmacological approach to panic disorder during pregnancy, The Journal of Maternal-Fetal & Neonatal Medicine, 2015, 1

    CrossRef

  2. 2
    Andrea V. Margulis, Kristin Palmsten, Susan E. Andrade, Rachel A. Charlton, Janet R. Hardy, William O. Cooper, Sonia Hernández-Díaz, Beginning and duration of pregnancy in automated health care databases: review of estimation methods and validation results, Pharmacoepidemiology and Drug Safety, 2015, 24, 4
  3. 3
    Gail Erlick Robinson, Controversies About the Use of Antidepressants in Pregnancy, The Journal of Nervous and Mental Disease, 2015, 203, 3, 159

    CrossRef

  4. 4
    Marloes T. Bazelier, Irene Eriksson, Frank Vries, Marjanka K. Schmidt, Jani Raitanen, Jari Haukka, Jakob Starup-Linde, Marie L. De Bruin, Morten Andersen, Data management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: a systematic literature review, Pharmacoepidemiology and Drug Safety, 2015, 24, 9
  5. 5
    B. Spodniaková, M. Halmo, P. Nosáľová, Electroconvulsive therapy in pregnancy - A review, Journal of Obstetrics and Gynaecology, 2015, 35, 7, 659

    CrossRef

  6. 6
    G. Ganesh Konduri, Joseph Menzin, Molly Frean, Terry Lee, Jim Potenziano, Joel Singer, Inhaled nitric oxide in term/late preterm neonates with hypoxic respiratory failure: estimating the financial impact of earlier use, Journal of Medical Economics, 2015, 1

    CrossRef

  7. 7
    Vinay Sharma, Sara Berkelhamer, Satyan Lakshminrusimha, Persistent pulmonary hypertension of the newborn, Maternal Health, Neonatology and Perinatology, 2015, 1, 1

    CrossRef

  8. 8
    Cheryl A. Anderson, Carol Lieser, Prenatal depression, The Nurse Practitioner, 2015, 40, 7, 38

    CrossRef

  9. 9
    Etienne Weisskopf, Céline J Fischer, Myriam Bickle Graz, Mathilde Morisod Harari, Jean-François Tolsa, Olivier Claris, Yvan Vial, Chin B Eap, Chantal Csajka, Alice Panchaud, Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence, Expert Opinion on Drug Safety, 2015, 14, 3, 413

    CrossRef

  10. 10
    Therapie Psychischer Erkrankungen, 2015,

    CrossRef

  11. 11
    Katherine L Wisner, Christof Schaefer, Drugs During Pregnancy and Lactation, 2015,

    CrossRef

  12. 12
    Kimberly A. Yonkers, Katherine A. Blackwell, Janis Glover, Ariadna Forray, Antidepressant Use in Pregnant and Postpartum Women, Annual Review of Clinical Psychology, 2014, 10, 1, 369

    CrossRef

  13. 13
    Lauren M. Osborne, Catherine A. Birndorf, Lauren E. Szkodny, Katherine L. Wisner, Returning to tricyclic antidepressants for depression during childbearing: clinical and dosing challenges, Archives of Women's Mental Health, 2014, 17, 3, 239

    CrossRef

  14. 14
    Asher Ornoy, Gideon Koren, Selective serotonin reuptake inhibitors in human pregnancy: On the way to resolving the controversy, Seminars in Fetal and Neonatal Medicine, 2014, 19, 3, 188

    CrossRef

  15. 15
    Gillian E. Hanley, Tim F. Oberlander, The effect of perinatal exposures on the infant: Antidepressants and depression, Best Practice & Research Clinical Obstetrics & Gynaecology, 2014, 28, 1, 37

    CrossRef

  16. 16
    Gökben Hızlı Sayar, Eylem Ozten, Evren Tufan, Cem Cerit, Gaye Kağan, Nesrin Dilbaz, Nevzat Tarhan, Transcranial magnetic stimulation during pregnancy, Archives of Women's Mental Health, 2014, 17, 4, 311

    CrossRef

  17. 17
    Jayasree Nair, Satyan Lakshminrusimha, Update on PPHN: Mechanisms and treatment, Seminars in Perinatology, 2014, 38, 2, 78

    CrossRef

  18. 18
    Therapie Psychischer Erkrankungen, 2014,

    CrossRef

  19. 19
    Andrea V. Margulis, Soko Setoguchi, Murray A. Mittleman, Robert J. Glynn, Colin R. Dormuth, Sonia Hernández-Díaz, Algorithms to estimate the beginning of pregnancy in administrative databases, Pharmacoepidemiology and Drug Safety, 2013, 22, 1
  20. You have free access to this content20
    N. Byatt, K. M. Deligiannidis, M. P. Freeman, Antidepressant use in pregnancy: a critical review focused on risks and controversies, Acta Psychiatrica Scandinavica, 2013, 127, 2
  21. 21
    Robin H. Steinhorn, Diagnosis and treatment of pulmonary hypertension in infancy, Early Human Development, 2013, 89, 11, 865

    CrossRef

  22. 22
    P. G. J. ter Horst, H. J. Bos, L. T. W. de Jong-van de Berg, B. Wilffert, In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children, European Journal of Clinical Pharmacology, 2013, 69, 3, 541

    CrossRef

  23. 23
    Karin E. Johnson, Sarah J. Beaton, Susan E. Andrade, T. Craig Cheetham, Pamela E. Scott, Tarek A. Hammad, Inna Dashevsky, William O. Cooper, Robert L. Davis, Pamala A. Pawloski, Marsha A. Raebel, David H. Smith, Sengwee Toh, De-Kun Li, Katherine Haffenreffer, Sascha Dublin, Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes, Pharmacoepidemiology and Drug Safety, 2013, 22, 7
  24. 24
    Rebecca A. Harrington, Li-Ching Lee, Rosa M. Crum, Andrew W. Zimmerman, Irva Hertz-Picciotto, Serotonin Hypothesis of Autism: Implications for Selective Serotonin Reuptake Inhibitor Use during Pregnancy, Autism Research, 2013, 6, 3
  25. 25
    Erica M. Richards, Jennifer L. Payne, The management of mood disorders in pregnancy: alternatives to antidepressants, CNS Spectrums, 2013, 18, 05, 261

    CrossRef

  26. 26
    A. D. Domar, V. A. Moragianni, D. A. Ryley, A. C. Urato, The risks of selective serotonin reuptake inhibitor use in infertile women: a review of the impact on fertility, pregnancy, neonatal health and beyond, Human Reproduction, 2013, 28, 1, 160

    CrossRef

  27. 27
    Andrea J Rapkin, Erin I Lewis, Treatment of premenstrual dysphoric disorder, Women's Health, 2013, 9, 6, 537

    CrossRef

  28. 28
    Gerald Simonneau, Michael A. Gatzoulis, Ian Adatia, David Celermajer, Chris Denton, Ardeschir Ghofrani, Miguel Angel Gomez Sanchez, R. Krishna Kumar, Michael Landzberg, Roberto F. Machado, Horst Olschewski, Ivan M. Robbins, Rogiero Souza, Updated Clinical Classification of Pulmonary Hypertension, Journal of the American College of Cardiology, 2013, 62, 25, D34

    CrossRef

  29. 29
    Qian Li, Susan E. Andrade, William O. Cooper, Robert L. Davis, Sascha Dublin, Tarek A. Hammad, Pamala A. Pawloski, Simone P. Pinheiro, Marsha A. Raebel, Pamela E. Scott, David H. Smith, Inna Dashevsky, Katherine Haffenreffer, Karin E. Johnson, Sengwee Toh, Validation of an algorithm to estimate gestational age in electronic health plan databases, Pharmacoepidemiology and Drug Safety, 2013, 22, 5
  30. 30
    Geert W. ‘t Jong, Thomas Einarson, Gideon Koren, Adrienne Einarson, Antidepressant use in pregnancy and persistent pulmonary hypertension of the newborn (PPHN): A systematic review, Reproductive Toxicology, 2012, 34, 3, 293

    CrossRef

  31. 31
    JULIANNE TOOHEY, Depression During Pregnancy and Postpartum, Clinical Obstetrics and Gynecology, 2012, 55, 3, 788

    CrossRef

  32. You have free access to this content32
    Lesley H. Curtis, Mark G. Weiner, Denise M. Boudreau, William O. Cooper, Gregory W. Daniel, Vinit P. Nair, Marsha A. Raebel, Nicolas U. Beaulieu, Robert Rosofsky, Tiffany S. Woodworth, Jeffrey S. Brown, Design considerations, architecture, and use of the Mini-Sentinel distributed data system, Pharmacoepidemiology and Drug Safety, 2012, 21,
  33. 33
    Lyn Colvin, Linda Slack-Smith, Fiona J. Stanley, Carol Bower, Early Morbidity and Mortality Following In Utero Exposure to Selective Serotonin Reuptake Inhibitors, CNS Drugs, 2012, 26, 7, e1

    CrossRef

  34. 34
    REBECCA L BROMLEY, ANGELIKA WIECK, DARIA MAKAROVA, CLARE TOWER, AMANDA WOOD, JILL CLAYTON-SMITH, FETAL EFFECTS OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR TREATMENT DURING PREGNANCY: IMMEDIATE AND LONGER TERM CHILD OUTCOMES, Fetal and Maternal Medicine Review, 2012, 23, 3-4, 230

    CrossRef

  35. 35
    Megan Galbally, Salvatore Gentile, Andrew J. Lewis, Further Findings Linking SSRIs During Pregnancy and Persistent Pulmonary Hypertension of the Newborn, CNS Drugs, 2012, 26, 10, 813

    CrossRef

  36. 36
    Luke E. Grzeskowiak, Andrew L. Gilbert, Janna L. Morrison, Investigating outcomes associated with medication use during pregnancy: A review of methodological challenges and observational study designs, Reproductive Toxicology, 2012, 33, 3, 280

    CrossRef

  37. 37
    René Ernst Nielsen, Per Damkier, Pharmacological treatment of unipolar depression during pregnancy and breast-feeding—A clinical overview, Nordic Journal of Psychiatry, 2012, 66, 3, 159

    CrossRef

  38. 38
    Heli Malm, Prenatal Exposure to Selective Serotonin Reuptake Inhibitors and Infant Outcome, Therapeutic Drug Monitoring, 2012, 34, 6, 607

    CrossRef

  39. 39
    Femi Oyebode, Abhinav Rastogi, Giles Berrisford, Floriana Coccia, Psychotropics in pregnancy: Safety and other considerations, Pharmacology & Therapeutics, 2012, 135, 1, 71

    CrossRef

  40. 40
    Orna Diav-Citrin, Asher Ornoy, Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?, Obstetrics and Gynecology International, 2012, 2012, 1

    CrossRef

  41. 41
    Ken Lim, Ari Sanders, Ursula Brain, Wayne Riggs, Tim F. Oberlander, Dan Rurak, Third trimester fetal pulmonary artery Doppler blood flow velocity characteristics following prenatal selective serotonin reuptake inhibitor (SSRI) exposure, Early Human Development, 2012, 88, 8, 609

    CrossRef

  42. 42
    James A. Taylor, Jeffrey A. Wright, David Woodrum, Avery's Diseases of the Newborn, 2012,

    CrossRef

  43. 43
    Arzneimittel in Schwangerschaft und Stillzeit, 2012,

    CrossRef

  44. 44
    Megan Galbally, Martien Snellen, Andrew J. Lewis, A review of the use of psychotropic medication in pregnancy, Current Opinion in Obstetrics and Gynecology, 2011, 23, 6, 408

    CrossRef

  45. 45
    Ariela Frieder, Antidepressant use during pregnancy, Expert Review of Obstetrics & Gynecology, 2011, 6, 3, 285

    CrossRef

  46. 46
    Laura Lorenzo, Barbara Byers, Adrienne Einarson, Antidepressant use in pregnancy, Expert Opinion on Drug Safety, 2011, 10, 6, 883

    CrossRef

  47. 47
    Salvatore Gentile, Drug treatment for mood disorders in pregnancy, Current Opinion in Psychiatry, 2011, 24, 1, 34

    CrossRef

  48. 48
    Luke E. Grzeskowiak, Andrew L. Gilbert, Janna L. Morrison, Investigating Outcomes Following the Use of Selective Serotonin Reuptake Inhibitors for Treating Depression in Pregnancy, Drug Safety, 2011, 34, 11, 1027

    CrossRef

  49. 49
    Edeltraut Garbe, Marc Suling, Sebastian Kloss, Christina Lindemann, Ulrike Schmid, Linkage of mother–baby pairs in the German Pharmacoepidemiological Research Database, Pharmacoepidemiology and Drug Safety, 2011, 20, 3
  50. 50
    M. T. R. Roofthooft, A. Elema, K. A. Bergman, R. M. F. Berger, Patient Characteristics in Persistent Pulmonary Hypertension of the Newborn, Pulmonary Medicine, 2011, 2011, 1

    CrossRef

  51. 51
    Maria Muzik, Kelsie Thelen, Katherine Lisa Rosenblum, Perinatal depression: detection and treatment, Neuropsychiatry, 2011, 1, 2, 179

    CrossRef

  52. 52
    Justin L. C. Bilszta, Shauna Tsuchiya, Kwiwon Han, Anne E. Buist, Adrienne Einarson, Primary care physician’s attitudes and practices regarding antidepressant use during pregnancy: a survey of two countries, Archives of Women's Mental Health, 2011, 14, 1, 71

    CrossRef

  53. 53
    D. Gimeno Álvarez, F. Ferre Navarrete, Protocolo de actuación para el uso de psicofármacos en el embarazo, Medicine - Programa de Formación Médica Continuada Acreditado, 2011, 10, 86, 5855

    CrossRef

  54. 54
    S. Berger, K.-J. Bär, Seelische Erkrankungen in der Schwangerschaft, Der Gynäkologe, 2011, 44, 12, 982

    CrossRef

  55. 55
    Dan Rurak, Ken Lim, Ari Sanders, Ursula Brain, Wayne Riggs, Tim F Oberlander, Third Trimester Fetal Heart Rate and Doppler Middle Cerebral Artery Blood Flow Velocity Characteristics During Prenatal Selective Serotonin Reuptake Inhibitor Exposure, Pediatric Research, 2011, 70, 1, 96

    CrossRef

  56. 56
    Madeleine A. Becker, Tal E. Weinberger, Lex Denysenko, Elisabeth J. S. Kunkel, Maternal-Fetal Evidence Based Guidelines, 2011,

    CrossRef

  57. 57
    Stephen A Contag, Cheryl Bushnell, Contemporary management of migrainous disorders in pregnancy, Current Opinion in Obstetrics and Gynecology, 2010, 22, 6, 437

    CrossRef

  58. 58
    M. Reis, B. Källén, Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data, Psychological Medicine, 2010, 40, 10, 1723

    CrossRef

  59. 59
    M. Soufia, J. Aoun, M.-A. Gorsane, M.-O. Krebs, ISRS et grossesse : revue de la littérature, L'Encéphale, 2010, 36, 6, 513

    CrossRef

  60. 60
    Orit Avni-Barron, Kelly Hoagland, Christina Ford, Laura J Miller, Preconception planning to reduce the risk of perinatal depression and anxiety disorders, Expert Review of Obstetrics & Gynecology, 2010, 5, 4, 421

    CrossRef

  61. 61
    Katherine L. Wisner, SSRI treatment during pregnancy: are we asking the right questions?, Depression and Anxiety, 2010, 27, 8
  62. 62
    Marlene P. Freeman, Melinda F. Davis, Supportive psychotherapy for perinatal depression: preliminary data for adherence and response, Depression and Anxiety, 2010, 27, 1
  63. 63
    Lee S. Cohen, Betty Wang, Ruta Nonacs, Adele C. Viguera, Elizabeth L. Lemon, Marlene P. Freeman, Treatment of Mood Disorders During Pregnancy and Postpartum, Psychiatric Clinics of North America, 2010, 33, 2, 273

    CrossRef

  64. 64
    Betty Wang, Marlene P. Freeman, Ruta Nonacs, Adele C. Viguera, Lee S. Cohen, Massachusetts General Hospital Handbook of General Hospital Psychiatry, 2010,

    CrossRef

  65. 65
    G. Ganesh Konduri, U. Olivia Kim, Advances in the Diagnosis and Management of Persistent Pulmonary Hypertension of the Newborn, Pediatric Clinics of North America, 2009, 56, 3, 579

    CrossRef

  66. 66
    JENNIFER L. PAYNE, SAMANTHA MELTZER-BRODY, Antidepressant Use During Pregnancy: Current Controversies and Treatment Strategies, Clinical Obstetrics and Gynecology, 2009, 52, 3, 469

    CrossRef

  67. 67
    Raymond W. Lam, Sidney H. Kennedy, Sophie Grigoriadis, Roger S. McIntyre, Roumen Milev, Rajamannar Ramasubbu, Sagar V. Parikh, Scott B. Patten, Arun V. Ravindran, Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults., Journal of Affective Disorders, 2009, 117, S26

    CrossRef

  68. 68
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2009, 18, 6
  69. 69
    Jacyntha Sterling, Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy, Hospital Pharmacy, 2009, 44, 5, 439

    CrossRef

  70. 70
    Marco Tuccori, Arianna Testi, Luca Antonioli, Matteo Fornai, Sabrina Montagnani, Narcisa Ghisu, Rocchina Colucci, Tiberio Corona, Corrado Blandizzi, Mario Del Tacca, Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: A review, Clinical Therapeutics, 2009, 31, 1426

    CrossRef

  71. 71
    Megan Galbally, Andrew J. Lewis, Jarrad Lum, Anne Buist, Serotonin discontinuation syndrome followingin uteroexposure to antidepressant medication: prospective controlled study, Australian and New Zealand Journal of Psychiatry, 2009, 43, 9, 846

    CrossRef

  72. 72
    Peter Brust, Marjorie Hamburger, Patricia Larkin, Transport of the Neonatal Patient With Persistent Pulmonary Hypertension, Newborn and Infant Nursing Reviews, 2009, 9, 4, 219

    CrossRef

  73. 73
    Susan E. Andrade, Marsha A. Raebel, Denise Boudreau, Robert L. Davis, Katherine Haffenreffer, Pamala A. Pawloski, Sengwee Toh, Richard Platt, Health Maintenance Organizations/Health Plans,
  74. 74
    Jennifer L. Payne, Susan G. Kornstein, Psychiatric Conditions During Peripartum and Perimenopause,
  75. 75
    Teri Pearlstein, Jami Star, Psychiatric Disorders in Pregnancy,